Vendor Notebook: AI tackles patient deterioration, obesity and stroke | Healthcare IT News

Stroke AI imaging. The U.S. Food and Drug Administration has cleared San Mateo, California-based RapidAI’s AngioFlow module, the company said.

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positivepositive.


Media Trust Score100%